Signed in as:
filler@godaddy.com
PharmD USA, LLC, with over a decade of expertise, provides specialized clinical and pharmaceutical consulting services to federal and state-owned skilled nursing home facilities, veterans homes, and a variety of other environments, conducting monthly visits at each location. Our comprehensive solutions focus on high-quality care, regulatory compliance, and continuous improvement, ensuring the safety and well-being of residents. Our team of licensed pharmacists and healthcare professionals conducts thorough Medication Regimen Reviews (MRRs) and collaborates closely with facility staff to implement best practices in medication management. With extensive experience across multiple states, we deliver the highest standards of care, compliance, and operational excellence, positioning us as a trusted partner for superior pharmaceutical care.
PharmD USA’s consultant pharmacists bring the same rigor to Skilled-Nursing Facilities (SNFs) and residential treatment programs that we deliver in acute-care settings—only now the focus is on long-stay, high-acuity residents. Our clinicians arrive on a fixed schedule to perform comprehensive Medication Regimen Reviews (MRRs) and peer audits. We confirm psychotropic‐and high-risk-drug appropriateness, flag drug–drug and drug-disease interactions, reconcile labs, and benchmark each prescriber’s patterns against CMS F-tag guidance and best-practice standards—driving safer, more consistent care for your residents.
At every visit we dive into the nuts and bolts of medication management: inspecting carts, med rooms, refrigerators, emergency kits, and controlled-substance logs; observing med-pass technique; and auditing crash carts, G-tube storage, and expiration tracking. Deficiencies flow straight into your QAPI plan with clear, time-stamped corrective actions—turning survey readiness into a standing operating rhythm instead of a last-minute scramble.
We chair your Medication Management / Pharmacy & Therapeutics (or QAA/QAPI) meetings, bringing data dashboards that spotlight antipsychotic gradual-dose-reduction (GDR) success rates, benzodiazepine taper progress, antibiotic-day-of-therapy trends, and fall-risk–sedation correlations. Each metric feeds CQI projects we revisit during subsequent rounds, ensuring measurable progress and bulletproof documentation.
All work is cross-walked to CMS State Operations Manual (F-tags 758, 760, 757, tag 329), DEA rules, state departments of health, Joint Commission, and board-of-pharmacy standards. Post-visit reports include detailed checklists, gap analyses, and evidence packets so your facility walks into surveys with confidence—and often earns commendations instead of citations.
Need stronger policies? We draft and refine standing orders, emergency-kit formularies, automatic therapeutic substitutions, psychotropic-review algorithms, antibiotic-stewardship protocols, and med-pass SOPs—each designed to exceed the expectations of CMS, DEA, and local surveyors. Partner with PharmD USA and turn regulatory pressure into a competitive advantage while elevating resident safety and therapeutic outcomes.
PharmD USA turns medication management into a strategic advantage. With our pharmacists on site and on call, your SNF or residential program moves from last-minute fixes to data-driven excellence—boosting safety scores, tightening compliance, and proving value to families, payers, and regulators alike. Let’s convert regulatory pressure into resident-centered wins and walk into every survey with confidence. Ready to elevate care? Reach out and we’ll build the roadmap together.
Today | Closed |
Copyright © 2025 PharmD USA - All Rights Reserved.